A group at Harvard has set out to expand diabetes research beyond the laboratory and to solicit the ideas of citizens, according to an article from Science 20.
The 12 winners of The Challenge contest, which was launched in February, each receive a $2,500 prize. The plan is to tap the Harvard research community to submit proposals that further some of the winning submissions.
The winning submissions include:
* ‘The (more…)
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the first European patient was enrolled in DEFEND-2, a confirmatory (more…)
News outlets report on how the delivery of health care is being changed by empowered patients.
USA Today: “In the past, most patients placed their entire trust in the hands of their physician. Your doc said you needed a certain medical test, you got it. Not so much anymore. Though some doctors find the newer ‘empowered’ patients taxing, others … welcome involvement and questions, especially since they recognize more (more…)
A federal court decision has blocked a White House policy allowing more embryonic stem cell research, a change that research advocates say will postpone long-awaited breakthroughs.
The ruling by chief judge Royce Lamberth of Federal District Court for the District of Columbia, granted a temporary injunction rescinding a 2009 executive order by President Obama loosening constraints on the research, saying that the president had violated (more…)
U.S. Chief District Court Judge Royce Lamberth in Washington ruled on August 23 that federal funding for embryonic stem–cell research was barred‚ according to a law prohibiting federal funds to be used for research in which an embryo is destroyed.
In his ruling‚ the judge rejected the Obama Administration’s argument that embryonic stem–cell research itself does not cause the destruction of embryos. Stem cells derived from embryos‚ (more…)